Upadhyay's expertise is in abortion safety and access in the U.S., state-level abortion restrictions, and medication abortion. She is Principal Investigator of the California Home Abortion by Telehealth study which evaluates the safety, effectiveness, and acceptability of telehealth for medication abortion. She is also leading a trial on interest in a late period pill, using misoprostol alone.
Quote: "The safety of medication abortion is well documented in research published in over 100 peer-reviewed journal articles. It has been used in the U.S. for over 20 years by over 5 million patients. In our longitudinal cohort study of over 11,000 patients, we found a safety rate of 99.7%."